STUDY DATA OF KRAS- AND RAS-UNMUTATED (WILD) TYPE OF COLORECTAL CANCER
Analysis of latest trials, comparing treatment schemes including chemotherapy with anti-EGFR monoclonal peppermint smoothie hibiscus antibodies or bevacizumab is presented in this article.The data in these trials is inconsistent, but detailed analysis of FIRE-3 trial allows to distinguish a wild-type RAS patient group that benefits most from chemot